Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool June 22, 2010 Jeff Fischer	4 Reasons to Sell a Stock Sell decisions are difficult, but guidelines help.
The Motley Fool June 18, 2009 Jeff Fischer	4 Reasons to Sell a Stock When to jettison a stock is a difficult decision, however, these guidelines can make selling decisions easier.
The Motley Fool October 26, 2011	A Brief History of Johnson & Johnson's Returns J&J shares are much more reasonably valued today than they were ten years ago; shareholders are unlikely to experience the same going forward.
The Motley Fool October 26, 2009 Adam J. Wiederman	Time to Sell and Lock in Your Gains With stocks up so much, it might be time to take some money off the table.
The Motley Fool August 24, 2010 Matt Koppenheffer	How Much Is Johnson & Johnson Worth? Is Johnson & Johnson's stock on sale?
The Motley Fool December 23, 2008 Selena Maranjian	Stock Buybacks Decline, at the Dumbest Time Ironically, this is probably one of the best times for companies to buy back their own stock. What a shame that more companies aren't seizing the opportunity.
The Motley Fool June 2, 2005 Matt Thurmond	Quality Systems or Not? Quality Systems' growth prospects were trading at a discount back in 2003. Those days are gone. But does that mean you shouldn't buy?
The Motley Fool October 12, 2007 Ryan Fuhrmann	Dueling Fools: Johnson & Johnson Bull The bullish opinion on J&J is that the company is handling current difficulties well, and the low stock price makes for a bargain for investors.
The Motley Fool March 20, 2009 Dayana Yochim	Fool Answers: Is Buy-and-Hold Dead? The buy-and-hold investing philosophy makes sense in "normal times." But is it really the best approach now that we may be in a recession of unprecedented magnitude?
The Motley Fool January 13, 2012 Morgan Housel	5 Companies You Can Buy Today Cheap by the numbers.
The Motley Fool September 17, 2010 Morgan Housel	5 Companies That Doubled Earnings While Their Stocks Went Nowhere When being "paid for performance" loses its mind.
The Motley Fool September 27, 2005 Marko Djuranovic	Knowing When to Sell: Part 2 If you'd no longer want to buy that stock sitting in your portfolio, it's time to cut it loose. Just make sure you're getting your fair value.
The Motley Fool January 12, 2009	2 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? Take a look at: Satyam Computer... Hansen Medical...
The Motley Fool March 24, 2011 Anand Chokkavelu	Rising Star Buy: Johnson & Johnson It's time to buy shares of Johnson & Johnson, the "health-care mutual fund."
The Motley Fool December 19, 2005 Rich Smith	Foolish Forecast: Clap for Palm? Palm shows its hand. Depending on a variety of factors, the company expects to report a profits number tomorrow that could range anywhere from $0.38 per diluted share, to $5.20 per share, or from $0.55 up to $0.65. Confusing? You bet.
The Motley Fool December 18, 2008 Selena Maranjian	Best Stock for 2009: Johnson & Johnson Johnson & Johnson is a stock that should let you sleep well at night in 2009.
The Motley Fool April 20, 2005 Jeff Hwang	From Poker to Investing: Always Look Ahead Focus on valuation, always look ahead, and keep it simple. A look at three suggestions about investing using poker theoretician Mike Caro's tips.
The Motley Fool January 21, 2009	3 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? Take a look at: Capital One Financial Corp. ... Fundtech Ltd. ... Fifth Third Bancorp...
The Motley Fool September 17, 2010 James Early	Today's Buy Opportunity: Johnson & Johnson The case for Johnson & Johnson is very simple: Here's a company that's been around forever, that pays a 3.5% dividend, and that's spread across arguably the most necessary sector (behind water and sewage): health care.
The Motley Fool November 23, 2005 Nathan Parmelee	Buy Google? No, Thanks Just how expensive is Google compared with other companies? For those buying shares today, Google would have to grow for another five or 10 years at rates that have never been seen before in order for the investment to make sense.
The Motley Fool December 21, 2006 Ryan Fuhrmann	Dueling Fools: Merck Bear Investors, because of its recent run-up, the risk/reward tradeoff is not very compelling. There are safer, more lucrative ways to invest in the space.
The Motley Fool August 27, 2007 Dave Mock	Is This Stock Cheap Enough? Valuing a stock is an inexact science. But here are three tips to tell when to buy, and when to pass.
The Motley Fool July 26, 2010 Dan Dzombak	Defend Yourself From the Double Dip With These 5 Stocks 5 cheap mega cap stocks to protect your portfolio
The Motley Fool January 15, 2009 Dan Caplinger	Beware of "Bargain" Stocks Before you go picking cheap stocks willy-nilly, make sure you're not cutting corners on your research -- or you could get a nasty shock in the future.
The Motley Fool November 22, 2006 Steven Mallas	Dueling Fools: Johnson & Johnson Bull Rebuttal Plenty of opportunities lie ahead for Johnson & Johnson, and even in down times, you've got a good defensive stock.
The Motley Fool November 29, 2007 Anders Bylund	Mano a Mano Over Johnson & Johnson A look back at the past year at Johnson & Johnson.
The Motley Fool December 29, 2009 Jennifer Schonberger	7 Companies Whose Managers Eat Their Own Cooking When it comes to investing, it's smart to pick out companies whose leaders are willing to eat alongside you, as it were, by owning a big equity stake in the company.
BusinessWeek January 30, 2006 Robert Barker	Guidant Or No, J&J Is A Buy To Wall Street, Johnson & Johnson has been sounding like Dumb & Dumber.
The Motley Fool October 27, 2009 Brian Orelli	Pfizer's and Merck's Loss Is These Companies' Gain Are Pfizer and Merck too busy integrating now to take advantage of additional acquisitions?
The Motley Fool June 14, 2010 Todd Wenning	One of the Riskiest Investments You Can Make You can make money buying shares of well-run companies; there just needs to be another factor the market is missing, in order for you to buy them at the right price.
The Motley Fool May 27, 2005 Stephen D. Simpson	Once More With Merck Merck has had a busy spring, but are investors any better off?
The Motley Fool October 30, 2007 Philip Durell	World's Scariest Stock: Research In Motion Great product, great company, but valuation has become too high. Investors, take note.
The Motley Fool January 28, 2011 Anand Chokkavelu	10 Core Stocks: A Johnson & Johnson Update The steady reliability of J&J stock will comfort the core of your portfolio when the market gets a boo-boo.
The Motley Fool May 10, 2005	Fair Value, Explained Don't confuse a stock's price with its fair value.
The Motley Fool October 22, 2010 Anand Chokkavelu	7 Big Pharma Stocks Near 52-Week Lows Trolling the bottom for upside potential.
The Motley Fool September 24, 2010 Anand Chokkavelu	10 Core Stocks for Your Portfolio: Johnson & Johnson The health care behemoth makes the list
The Motley Fool January 5, 2009 Rich Smith	This Just In: Upgrades and Downgrades Bernstein Research starts off the New Year with a pair of downgrades, knocking AT&T down to "market perform" and kicking Verizon down one notch further, to "underperform."
The Motley Fool December 2, 2005 Tim Beyers	The Rewards of Valuation Maybe high school math isn't so useless, after all. What do you say when two of your better stocks get picked up for right around the price you expected? Thank goodness for valuation.
The Motley Fool February 10, 2006 Stephen D. Simpson	UTStarcom Still a Mess A contract revenue recognition problem serves as a reminder of the management quality issues here. Valuation is enticingly low, and simply a mediocre performance from management should be enough to make this company profitable.
The Motley Fool January 19, 2012 Dan Caplinger	Why Falling Home Ownership Is a Good Thing Don't assume that all the news on housing is bad.
The Motley Fool January 19, 2011 Alex Dumortier	7 Stocks You Need to Watch This Earnings Season These seven stocks could exhibit greater volatility than the average as well as strategy to manage that risk: Equinix... Goodyear Tire & Rubber... MBIA... United States Steel... Wynn Resorts... Green Mountain Coffee... Sirius XM...
The Motley Fool November 18, 2011 Morgan Housel	4 Stocks About as Cheap as They've Ever Been Here are four great companies waiting to be bought: Apple... Wal-Mart... Hewlett-Packard... Wells Fargo...
The Motley Fool August 11, 2010 David Meier	Does Bill Miller Think Johnson & Johnson Is Attractive? Johnson & Johnson fits Miller's criteria perfectly. It pays a 3.6% dividend that has been growing 11.1%, on average, for the past five years.
The Motley Fool January 20, 2011 Alex Dumortier	Why This Pro Is Satisfied Matching the Market A portfolio that matches the index's performance in bull markets and outperforms during bear markets/corrections will end up smashing the index over the long term.
The Motley Fool August 18, 2010 Tim Hanson	Don't Buy This Stock ... Yet Promising names that aren't quite buys.
The Motley Fool May 31, 2007 Ryan Fuhrmann	Dueling Fools: Eli Lilly Bull Rebuttal Investors need to keep looking for further proof that Lilly's valuation premium to its peers is fully warranted, but if current trends are any indication, its growth prognosis could lead the industry.
The Motley Fool December 18, 2003 Jeff Fischer	A Tougher 2004? After 2003 handed investors a fat kiss in the form of double-digit gains across the board, we're entering 2004 with fast-evolving economic conditions: Deficit spending, increasing money supply, and growing productivity point to inflation and rising interest rates.
The Motley Fool August 21, 2008 Tim Beyers	Palm's Treo Goes Pro Palm's revamped engineering team announces the new Treo Pro.
The Motley Fool June 4, 2007 Mac Greer	Fool Video: Invest in Palm, Invest in the Next iPod? Palm sells 25% of its business and brings in the man behind the iPod. Should investors buy Palm?
The Motley Fool November 22, 2006 Brian Lawler	Dueling Fools: Johnson & Johnson Bear Rebuttal The bottom line is that investors are putting their faith in the ability of J&J's management to acquire its way to renewing top-line growth in the coming years.